Mayo Clinic proceedings
-
Mayo Clinic proceedings · Jul 2021
Meta AnalysisJanus Kinase Inhibitors and Risk of Venous Thromboembolism: A Systematic Review and Meta-analysis.
To assess the risk of venous thromboembolism (VTE) in patients treated with Janus kinase (JAK) inhibitors in clinical trials. ⋯ We found insufficient evidence to support an increased risk of JAK inhibitor-associated VTE based on currently available data.